Evidence Based Birth®

In this episode, Dr. Rebecca Dekker and investigative journalist Sarah Kliff of The New York Times explore the intricate world of cord blood banking. Sarah shares insights from her article, "Promised Cures, Tainted Cells," which explored cord blood banking practices, their marketing claims, and the stark contrast between public and private banking systems.   Together, they discuss: The differences between public and private cord blood banks Marketing tactics and their impact on parents The decline in the medical utility of cord blood over the last decade Ethical concerns, such as contamination, low stem cell counts, and hidden collection fees Sarah also shares the stories of families who invested in private banking, only to find their samples unusable when needed. This episode sheds light on the decisions surrounding cord blood banking and provides a look at the system's pitfalls.   Join us at the EBB Conference (virtually) this March by registering here! You can also see if the EBB Pocket